BackFoley Trasimene Acquisition Overview

Foley Trasimene Acquisition Net Income

Latest net income for WPF: $-2B, below the sector sector average of $90M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

$1.00M
100.09% YoY

As of Jun 2026

Annual Net Income (TTM)

-$2.00B
75.42% YoY

Trailing 12 months ending Jun 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Foley Trasimene Acquisition (WPF) FAQ

As of the most recent data (June 2026), WPF shows a net income of $-2B. That compares with $-1.1B in the prior-year period — down 75.4% year over year. That is below the sector sector average of $90M. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, WPF's net income is now $-2B (was $-1.1B) — a 75.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Foley Trasimene Acquisition is outperforming or lagging.

The its sector sector average net income is about $90M. Foley Trasimene Acquisition is at $-2B, which is lower that average. That is roughly 2320.8% below the sector mean. Use the comparison chart on this page to see how WPF stacks up against individual peers as well.

Tracking WPF's net income over time shows whether Foley Trasimene Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $-2B That compares with $-1.1B in the prior-year period — down 75.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has Foley Trasimene Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-2B) with ownership activity and broader fundamentals.